Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹946.00up ₹2.10 (0.22%)BSE ₹942.40
Share price at the NSE close on 29 Oct 2026. Previous close ₹943.90.
29 Oct: open ₹943.90, high ₹956.10, low ₹937.30
52-week range of traded prices to 29 Oct 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,068 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 42.79
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 36.64
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.12
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 45,19840.5% delivered
Jubilant Pharmova shareholding disclosures
93 filed, newest first. Page 1 of 2.
Apr 2026
Aug 2025
Jun 2025
May 2025
Apr 2025
Jul 2024
19 Jul · Disclosure
Apr 2024
Jul 2023
19 Jul · Disclosure
May 2023
Apr 2022
Jul 2021
Apr 2021
Jan 2021
Jun 2020
Apr 2019
Apr 2018
Apr 2017
Mar 2017
Dec 2016
14 Dec · Disclosure
Nov 2016
25 Nov · Disclosure
Aug 2016
Jul 2016
Jun 2016
Apr 2016
Feb 2016
Jan 2016
Dec 2015
28 Dec · Disclosure
Nov 2015
Sep 2015
30 Sep · Disclosure
Aug 2015
May 2015
Apr 2015
Dec 2013
Sep 2013
May 2013
8 May · Disclosure
Compensation Committee of the Board of Directors in its meeting held on May 07, 2013, inter alia, has granted 12,187 (Twelve Thousands One Hundred and Eighty Seven) Options to eligible employees of the Company, in accordance with JLL Employees Stock Option Plan, 2011. Each option shall entitle the holder to acquire 1 equity share of Re. 1 of the Company at a price of Rs. 176.00 (Rupees One Hundred and Seventy Six only) per share. Since Jubilant Employees Welfare Trust is holding sufficient number of equity shares of the Company, it is envisaged to transfer the Shares from the Trust to beneficiaries upon exercise. As such, there would be no fresh issue of Shares by the Company and hence no dilution.